The protein tyrosine phosphatase SHP2 has been proposed to serve as a regulator of leptin signaling, but its specific roles are not well examined. To directly investigate the role of SHP-2, we employed dominant negative strategies in transfected cells. We show that a catalytically inactive mutant of SHP-2 blocks leptin-stimulated ERK phosphorylation by the long leptin receptor, ObRb. SHP-2 lacking two C-terminal tyrosine residues partially inhibits ERK phosphorylation. We find similar effects of the SHP-2 mutants after examining stimulation of an ERK-dependent egr-1 promoterconstruct by leptin. We also demonstrate ERK phosphorylation and egr-1 mRNA expression in the hypothalamus by leptin. Analysis of signaling by ObRb lacking intracellular tyrosine residues or by the short leptin receptor, ObRa, we conclude that two pathways are critical for ERK activation. One pathway does not require the intracellular domain of ObRb, while the other pathway requires tyrosine residue 985 of ObRb. The phosphatase activity of SHP-2 is required for both pathways, whereas activation of ERK via Y985 of ObRb also requires tyrosine phosphorylation of SHP-2. SHP-2 is thus a positive regulator of ERK by leptin receptors, and both the adaptor function and the phosphatase activity of SHP-2 are critical for this regulation.
Summary
The protein tyrosine phosphatase SHP2 has been proposed to serve as a regulator of leptin signaling, but its specific roles are not well examined. To directly investigate the role of SHP-2, we employed dominant negative strategies in transfected cells. We show that a catalytically inactive mutant of SHP-2 blocks leptin-stimulated ERK phosphorylation by the long leptin receptor, ObRb. SHP-2 lacking two C-terminal tyrosine residues partially inhibits ERK phosphorylation. We find similar effects of the SHP-2 mutants after examining stimulation of an ERK-dependent egr-1 promoterconstruct by leptin. We also demonstrate ERK phosphorylation and egr-1 mRNA expression in the hypothalamus by leptin. Analysis of signaling by ObRb lacking intracellular tyrosine residues or by the short leptin receptor, ObRa, we conclude that two pathways are critical for ERK activation. One pathway does not require the intracellular domain of ObRb, while the other pathway requires tyrosine residue 985 of ObRb. The phosphatase activity of SHP-2 is required for both pathways, whereas activation of ERK
Introduction
Leptin is a 16-kDa hormone derived from adipose tissue that acts on specific regions of the brain to regulate food intake, energy expenditure and neuroendocrine function in response to nutritional perturbations (1) (2) (3) (4) (5) . Lack of functional leptin or of leptin receptors produce severe obesity in mice and in rare cases in humans (1, (6) (7) (8) (9) (10) . The common form of human obesity is characterized by hyperleptinemia and leptin resistance that yet has to be explained (11) .
Leptin regulates the expression of several genes in the hypothalamus via direct actions on neurons expressing leptin receptors. This includes socs-3 (suppressor-ofcytokine-signaling) (12) , c-fos (13) and genes encoding neuropeptides that are involved in the regulation of appetite and body weight (14) , including NPY (15, 16) , AgRP (17) , CART (18) , POMC (19, 20) and TRH (21) . The intracellular signaling pathways by which leptin regulates these genes are unknown and further studies in this area are therefore likely to be critical for the understanding of the mechanism(s) leading to the leptin resistance characterizing human obesity.
Leptin is structurally related to cytokines and acts on receptors that belong to the cytokine-receptor superfamily (6) . Several different leptin receptor isoforms exists including a long form (ObRb), which is highly expressed in regions of the hypothalamus, and a short form (ObRa), which is highly expressed within microvessels of the bloodbrain barrier (6, 7, (22) (23) (24) . While ObRb has a 302 amino acid long intracellular domain, ObRa is predicted to encompass only a 34 residue cytoplasmic domain. Leptin receptors lack intrinsic catalytic activity, and analogous with other cytokine receptor systems, leptin stimulation results in activation of intracellular Janus tyrosine kinases (JAKs) that are associated with conserved JAK-binding motifs present in the membrane proximal region of leptin receptors (25, 26) . Activated JAKs then phosphorylate phosphotyrosine residues in the intracellular domain of ObRb (26) . ObRa does not contain any intracellular tyrosine residues. 4 The murine ObRb receptor contains three intracellular tyrosine residues, located at positions 985, 1077 and 1138. These amino acids are conserved among known species of long form leptin receptors. Tyrosine phosphorylation-sites provide binding motifs for src homology 2 (SH2)-domain containing proteins, such as STATs (signal transducer and activator of transcription) (27, 28) . Tyrosine 1138 is located 3 residues N-terminal to a glutamine residue (YXXQ), generating a consensus STAT3 binding motif (29) . STATs then become tyrosine phosphorylated in response to JAK activation and translocate to the nucleus to regulate gene transcription. Consistently, removal of Y1138 severely reduces leptin-induced STAT3 activation (30) (31) (32) (33) . Whereas several different STAT isoforms have been shown to be activated by leptin in cell systems (22, 30) , only STAT3 has been found to be activated in vivo in the hypothalamus (34) . The severely obese db/db mice lack the intracellular domain of ObRb (7, 8) , and therefore can not mediate activation of STAT3 in the hypothalamus (34) . It therefore seems likely, but yet unproven, that STAT3 activation is a crucial component in leptin's pathway(s) to regulate body weight.
In addition to STAT3 activation, other key signaling components are likely to be regulated by leptin receptors. In vitro or in vivo studies show that leptin can stimulate insulin receptor substrate phosphorylation (26) , PI3K activity (35) (36) (37) , and MAPK (ERK) activity (26, 37, 38) . Recent data suggest that tyrosine 985 is required for maximal activation of the ERK pathway by leptin (33) . Furthermore, the SH2-domain containing protein tyrosine phosphatase, SHP-2 (see Review 39), binds to Y985 and this site is required for tyrosine phosphorylation of SHP-2 following leptin treatment (32, 33, 40) . SHP-2 has been shown to play a positive role in mediating ERK activation by cytokine receptors and by receptor tyrosine kinases (41) (42) (43) (44) (45) . Studies also suggest that SHP-2 acts as both a negative and positive regulator of STAT signaling via different cytokine receptors (45) (46) (47) (48) . The roles of the phosphatase activity and tyrosine phosphorylation of SHP-2 in regulation of signaling pathways are not well characterized and may differ in different signaling systems.
Data suggest that Y985 of ObRb mediates negative regulation of the STAT pathway (32) . We have recently provided a mechanism for this observation by demonstrating that SOCS-3, a leptin-inducible SH2-domain containing protein, requires binding to phosphorylated Y985 to efficiently inhibit ObRb signaling (49) . We have previously shown that both ObRa and ObRb have the ability to stimulate the ERK pathway (26) and that SHP-2 is likely to play a positive role in ERK activation via Y985 of ObRb (33) . However, since the exact requirements for different leptin receptor domains and SHP-2 functions are unclear in leptin signaling to the ERK pathway, we decided to more carefully examine this by applying dominant-negative SHP-2 strategies.
Our data show that SHP-2 is a positive regulator of the ERK pathway by both short and long leptin receptors. We conclude that SHP-2 affects ERK activation via two pathways.
One pathway does not require the intracellular domain unique for ObRb, while the other requires tyrosine residue 985 of ObRb. The phosphatase activity of SHP-2 is required for both pathways, whereas activation of ERK via Y985 of ObRb also requires tyrosine phosphorylation of SHP-2. We speculate that SHP-2 is also an indirect positive regulator of STAT signaling by competitive inhibition of SOCS-3 binding to Y985. 7 Cells stably expressing mutant or wild type chimeric ELR isoforms were generated as described earlier (33) .
Cell Culture and Transient Transfection. CHO cells were grown in HAM's F12 medium supplemented with 10% fetal calf serum (FCS), 100 units/ml penicillin, and 10 µg/ml streptomycin at 37 o C in 5% CO 2 . COS-1 and 293 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS, 100 units/ml penicillin, and 10 µg/ml streptomycin at 37 o C in 5% CO 2 . All cells were serum-deprived for 12-15 h prior to stimulation with hormones. Cells were transfected with LipofectAMINE according to the recommendations by the manufacturer (GIBCO-BRL).
Cells were harvested by rinsing in ice-cold phosphate-buffered saline, and scraping into ice-cold lysis buffer (RIPA buffer supplemented with 2 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, 5 µg/ml leupeptin and 5 µg/ml aprotinin). Lysates were clarified by centrifugation and supernatants were immunoprecipitated as described below.
Immunoprecipitation and Immunoblotting. Immunoprecipitations were performed as described earlier by Bjørbaek et al. (26) . Briefly, clarified lysates were incubated at 4 o C with antibodies together with protein A-agarose beads. After 3 washes in ice-cold RIPA buffer, the samples were subjected to SDS-PAGE. Proteins were then transferred to nitrocellulose membranes and blocked in non-fat dry-milk or BSA. After incubation with antibodies, nitrocellulose membranes were washed and targeted proteins were detected using either enhanced chemiluminescence (ECL), as described by the manufacturer (Amersham Pharmacia International, Buckinghamshire, UK) or by using 125 I-Protein A (ICN). ERK phosphorylation by Western blotting. We found a modest but significant increase in phosphorylation in the leptin treated animals ( Figure 3A ). We next measured hypothalamic egr-1 mRNA levels after leptin treatment. Fasted C57Bl mice were injected ip with leptin and total hypothalamic RNA was isolated at different times after administration. We then employed quantitative 32 P-RT-PCR to measure egr-1 mRNA expression as described earlier for socs-3 mRNA (12). Radioactive PCR products from representative samples are shown in Figure 3B . Leptin rapidly stimulates hypothalamic egr-1 mRNA levels, reaching maximal levels at 30 minutes after injection. Expression levels returned to baseline levels at 3 hours. The results from several animals are quantified in Figure 3C . We have earlier demonstrated stimulation of socs-3 mRNA levels by leptin in the hypothalamus. SOCS-3 is an intracellular inhibitor of leptin signaling and socs-3 mRNA expression is stimulated by leptin in vivo (12) and in vitro (53) . The time course of socs-3 mRNA induction in the hypothalamus by leptin has not been reported. We found by quantitative 32 P-RT-PCR that the increase of socs-3 mRNA levels were slower as compared to egr-1, reaching maximal levels (4 fold above baseline)
at ~2 hours and returning to near baseline at 6 hours ( with results we have reported earlier using full-length ObRb (26) . These data show that the ERK pathway can be activated via JAK2 by a mechanism that does not require tyrosine phosphorylation of the leptin receptor. To specifically investigate the role of Y985 in ERK activation via JAK2, we transiently transfected ELR or ELR-985L into CHO cells. The cells were also co-transfected or not with low levels of JAK2 cDNA.
Consistent with results that we have reported earlier using 293 cells (33) , stimulation of HA-ERK1 phosphorylation by ELR-985L was much reduced as compared to ELR in the absence of JAK2 co-expression (Fig. 6B) . However, transfection of JAK2 significantly enhanced ligand-induced ERK1 phosphorylation by both ELR and ELR-985L (Fig. 6B) , although the levels were slightly lower for ELR-985L. These data show that in the absence of JAK2 co-transfection, maximal ERK activation requires Y985 of ObRb. On the other hand, co-expression of JAK2 leads to enhanced ERK phosphorylation that is largely independent of receptor phosphorylation. Combined, the data suggest that ERK1
and ERK2 can be activated by leptin via both a receptor-tyrosine dependent (Y985) and a receptor-tyrosine independent pathway. Furthermore, we conclude that the relative signaling via these two pathways may depend on cellular JAK2 activity levels. Following treatment with EPO for 10 minutes, cellular lysates were analyzed for ERK1 phosphorylation by Western blotting as described under Figure 1 . We found that the phosphorylation was completely blocked by the dominant negative SHP-2 C-S mutant (Fig. 7A) . However, there was no attenuation by SHP-2 Y2F, contrary to what was observed for wild type ObRb (Fig. 1) . To further strengthen this finding, we transiently transfected the short leptin receptor (ObRa), JAK2, HA-ERK1 together with SHP-2 constructs into CHO cells. As shown by Western blotting in Figure 7B , leptin-induced HA-ERK1 phosphorylation via ObRa was also blocked by SHP-2 C-S, but was unaffected by SHP-2 Y2F. Autoradiograms from several independent Western blots of ERK phosphorylation by ObRa (Fig. 7B) were quantified by laser-scanning PhosphoImager densitometry. The results are depicted in Figure 7C . (Figure 8 ).
Maximal activation of ERK via Y985 of
Ligand-dependent ERK phosphorylation via ObRb lacking all tyrosine residues is strongly enhanced by co-expression of JAK2, and the level is comparable to that of wild type ObRb. This is suggestive of a direct signaling pathway from JAK2 to the ERK We have earlier shown that ERK activation by leptin receptors is enhanced by JAK2 expression (26) . However, specific ERK activation via the short leptin receptor, ObRa, is much weaker than that of ObRb, when the much higher expression of ObRa is taken into account (26) . Similarly, leptin-stimulated JAK2 phosphorylation is more robust via ObRb as compared to ObRa (26) . The fact that both JAK2 and ERK activation is lower via ObRa may be explained by the lack the conserved Box-2 JAK-binding-motif in ObRa, but which is present in ObRb and in other long cytokine receptors of the family (25, 63) . The Box-2 motif is likely required for maximal JAK activation and for subsequent maximal stimulation of the ERK pathway. Thus, the more robust ERK signaling by ObRb, as compared to ObRa, is possibly caused by increased Box-2-mediated activation of JAK kinase activity which likely leads to enhanced ERK activation via both the "alternative" JAK-mediated pathway, and via increased phosphorylation of Y985 followed by enhanced SHP-2 tyrosine phosphorylation.
Interestingly, since ObRa does not contain Y985, ERK signaling via this receptor is unlikely to be regulated by SHP-2 phosphorylation or by feedback inhibition by SOCS-3, as is the case of ObRb. The relevance of this observation is presently unknown.
We also show for the first time that leptin rapidly stimulates the mRNA expression of the zinc-finger transcription factor, Egr-1, in the hypothalamus of mice.
Our transfection results suggest that this regulation by leptin occur by activation of the egr-1 promoter via activation of SHP-2 and of the ERK pathway. The role of the Egr-1 transcription factor in leptin action in the CNS, as well as the exact sites of activation within the hypothalamus, remains to be determined. Results from saline injected animals were normalized to 100% for each gene. 
